Evidence map›Paper›PMID 34162392›Full record

ArticleJournal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance2021

Prognostic value of perfusion cardiovascular magnetic resonance with adenosine triphosphate stress in stable coronary artery disease.

Ming-Yen Ng, Chi Yeung Chin, Pui Min Yap, Eric Yuk Fai Wan, JoJo Siu Han Hai, Stephen Cheung, Hung Fat Tse, Chiara Bucciarelli-Ducci, Dudley John Pennell, Kai-Hang Yiu

Open access · goldAbstract read
In one paragraph

Article in Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Ming-Yen NgDepartment of Diagnostic Radiology, The University of Hong Kong, Hong Kong, China. myng2@hku.hk.ORCID 0000-0001-9533-3892
Chi Yeung ChinDepartment of Diagnostic Radiology, The University of Hong Kong, Hong Kong, China.
Pui Min YapDepartment of Diagnostic Radiology, The University of Hong Kong, Hong Kong, China.
Eric Yuk Fai WanDepartment of Family Medicine and Primary Care, The University of Hong Kong, Hong Kong, China.
JoJo Siu Han HaiCardiology Division, Department of Medicine, The University of Hong Kong, Hong Kong, China.
Stephen CheungDepartment of Radiology, Queen Mary Hospital, Hong Kong, China.
Hung Fat TseCardiology Division, Department of Medicine, The University of Hong Kong, Hong Kong, China.
Chiara Bucciarelli-DucciRoyal Brompton and Harefield NHS Foundation Trust, London, UK.
Dudley John PennellRoyal Brompton and Harefield NHS Foundation Trust, London, UK.
Kai-Hang YiuCardiology Division, Department of Medicine, The University of Hong Kong, Hong Kong, China.
University of Hong Kong · HKQueen Mary Hospital · CNRoyal Brompton & Harefield NHS Foundation Trust · GBUniversity of Hong Kong - Shenzhen Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdenosine triphosphate (ATP) has been predominantly used in the Asia-Pacific region for stress perfusion cardiovascular magnetic resonance (CMR). We evaluated the prognosis of patients stressed using ATP, for which there are no current data.

methodsWe performed a retrospective longitudinal study from January 2016 to December 2020 and included 208 subjects with suspected obstructive coronary artery disease (CAD) who underwent ATP stress perfusion CMR. An inducible stress perfusion defect was defined as a subendocardial dark rim involving ≥ 1.5 segments that persisted for ≥ 6 beats during stress but not at rest. The primary outcome measure was a composite of major adverse cardiovascular events (MACE) including (1) cardiac death, (2) nonfatal myocardial infarction, (3) cardiac hospitalization, (4) late coronary revascularization. We compared outcomes in patients with and without perfusion defect using Kaplan-Meier and log rank tests. Significant predictors of MACE were identified using multivariable Cox regression analysis.

resultsMedian follow-up was 3.3 years. Patients with no stress perfusion defect had a lower incidence of MACE (p < 0.001), including lower cardiac hospitalization (p = 0.004), late coronary revascularization (p = 0.001) and cardiac death (p = 0.003). Significant independent predictors for MACE were stress induced perfusion defect (p < 0.001, hazard ratio [HR] = 3.63), lower left ventricular ejection fractino (LVEF) (p < 0.001, HR = 0.96) and infarct detected by late gadolinium enhancement (LGE) (p = 0.001, HR = 2.92).

conclusionPerfusion defects on ATP stress are predictive of MACE which is driven primarily by cardiac hospitalization, late coronary revascularization and cardiac death. Significant independent predictors of MACE were stress induced perfusion defect, lower LVEF and infarct detected by LGE.

Indexed as

Coronary Artery DiseaseAdenosine TriphosphateContrast MediaGadoliniumHumansLongitudinal StudiesMagnetic Resonance Imaging, CineMagnetic Resonance SpectroscopyPerfusionPredictive Value of TestsPrognosisRetrospective StudiesRisk AssessmentRisk FactorsVasodilator AgentsAdenosine TriphosphateContrast MediaGadoliniumVasodilator AgentsAdenosine triphosphateCardiovascular magnetic resonanceCoronary artery diseasePrognosisStress

Identifiers

PMID34162392
PMCPMC8223349
OpenAlexW3175509823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.